Fingerprint
Dive into the research topics of 'Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials
Geoffrey Y. Ku, Benjamin A. Haaland, Gilberto de Lima Lopes
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations